rTMS for adolescents: Safety and efficacy considerations

Psychiatry Research

Volumn 177, Issue 3, 2010, Pages 280-285

  D'Agati, Douglas ^a   Bloch, Yuval ^b   Levkovitz, Yechiel ^b   Reti, Irving ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHALVATA MENTAL HEALTH CENTER   (Israel)

Author keywords

Children; Depression; Seizure; Transcranial magnetic stimulation

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; MAPROTILINE; METHYLPHENIDATE; NEUROLEPTIC AGENT;

ADOLESCENT; AUDITORY THRESHOLD; CEREBRAL PALSY; CHILD PSYCHIATRY; CLINICAL EFFECTIVENESS; DEPRESSION; ELECTROMAGNETIC RADIATION; EPILEPTIC STATE; HEADACHE; HUMAN; HYPOMANIA; MANIA; MENTAL HEALTH; NEUROCARDIOGENIC SYNCOPE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAFETY; SEIZURE; SYNCOPE; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; CEREBRAL PALSY; CHILD; COGNITION DISORDERS; DEPRESSION; EPILEPSY; EQUIPMENT SAFETY; HUMANS; MEDLINE; NEUROPSYCHOLOGICAL TESTS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77952668564     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.03.004     Document Type: Review

References (75)

1. Alldredge B.K. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999, 53(Suppl 2):S68-S75.
2. Anderson B., Mishory A., Nahas Z., Borckardt J.J., Yamanaka K., Rastogi K., George M.S. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. Journal of ECT 2006, 1:49-53.
3. Barker A.T., Jalinous R., Freeston I.L. Non-invasive magnetic stimulation of the human motor cortex. Lancet 1985, 8437:1106-1107.
4. Bernabeu M., Orient F., Tormos J.M., Pascual-Leone A. Seizure induced by fast repetitive transcranial magnetic stimulation. Clinical Neurophysiology 2004, 115:1714-1715.
5. Bloch Y., Grisaru N., Harel E.V., Beitler G., Faivel N., Ratzoni G., Stein D., Levkovitz Y. Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. Journal of ECT 2008, 2:156-159.
6. Bourland J.D., Nyenhuis J.A., Schaefer D.J. Physiologic effects of intense MR imaging gradient fields. Neuroimaging Clinics of North America 1999, 2:363-377.
7. Brent D., Emslie G., Clarke G., Wagner K.D., Asarnow J.R., Keller M., Vitiello B., Ritz L., Iyengar S., Abebe K., Birmaher B., Ryan N., Kennard B., Hughes C., DeBar L., McCracken J., Strober M., Suddath R., Spirito A., Leonard H., Melhem N., Porta G., Onorato M., Zelazny J. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. The Journal of the American Medical Association 2008, 299:901-913.
8. Carpenter D.O., Sage C. Setting prudent public health policy for electromagnetic field exposures. Reviews on Environmental Health 2008, 2:91-117.
9. Chen R., Classen J., Gerloff C., Celnik P., Wassermann E.M., Hallett M., Cohen L.G. Depression of motor cortex excitability by low frequency trancranial magnetic stimulation. Neurology 1997, 48:1398-1403.
10. Chen C., Gerloff C., Classen J., Wassermann E., Hallett M., Cohen L. Safety of different inter-train intervals for repetitive transcranial magnetic stimulation and recommendations for safe ranges of stimulation parameters. Electroencephalography and Clinical Neurophysiology 1997, 105:415-421.
11. Coffey C.E., Lucke J., Weiner R.D., Krystal A.D., Aque M. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biological Psychiatry 1995, 10:713-720.
12. Collado-Corona M.A., Mora-Magana I., Cordero G.L., Toral-Martiñón R., Shkurovich-Zaslavsky M., Ruiz-Garcia M., González-Astiazarán A. Transcranial magnetic stimulation and acoustic trauma or hearing loss in children. Neurological Research 2001, 4:343-346.
13. Conca A., Konig P., Hausmann A. Transcranial magnetic stimulation induces 'pseudoabsence seizure'. Acta Psychiatrica Scandinavica 2000, 101:246-249.
14. Demirtas-Tatlided A., Mechanic-Hamilton D., Press D.Z. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refreactory depression: repoductibility and duration of the antidepressant effect in medication-free patients. Journal of Clinical Psychiatry 2008, 6:930-934.
15. Dolberg O., Schreiber S., Grunhaus L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biological Psychiatry 2001, 49:468-470.
16. Dolberg O.T., Dannon P.N., Schreiber S., Grunhaus L. Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disorder 2002, 4(Suppl. 1):94-95.
17. Edwards J.G., Long K.S., Sedgwick E.M., Wheal H.V. Antidepressants and convulsive seizures: clinical, electrocephalographic and phramacological aspects. Clinical Neuropharmacology 1986, 9:329-360.
18. Ella R., Zwanger P., Stampfer R., Preuss U.W., Müller-Siecheneder F., Möller H.J., Padberg F. Switch to mania after slow rTMS of the right prefrontal cortex. Journal of Clinical Psychiatry 2002, 3:249.
19. Erfuth A., Michael N., Mostert C., Arolt V. Euphoric mania and rapid transcranial magnetic stimulation. American Journal of Psychiatry 2000, 157:835-836.
20. Figiel G.S., Epstein C., McDonald W.M., Amazon-Leece J., Figiel L., Saldivia A., Glover S. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. Journal of Neuropsychiatry and Clinical Neurosciences 1998, 10:20-25.
21. Fitzgerald P.B., Brown T.L., Marston N.A., Daskalakis Z.J., De Castella A., Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Archives of General Psychiatry 2003, 60:1002-1008.
22. Fitzgerald P.B., Huntsman S., Gunewardene R., Kulkarni J., Daskalakis Z.J. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. International Journal of Neuropsychopharmacology 2006, 9:655-666.
23. Fitzgerald P.B., Hoy K., Daskalakis Z.J., Kulkarni J. A randomized trial of the anti-depressant effects of low-and high-frequency transcranial magnetic stimulation on treatment-resistant depression. Depression and Anxiety 2009, 3:229-234.
24. Franson K.L., Hay D.P., Neppe V., Dahdal W.Y., Mirza W.U., Grossberg G.T., Chatel D.M., Szwabo P.A., Kotegal S. Drug-induced seizures in the elderly. Causative agents and optimal management. Drugs & Aging 1995, 1:38-48.
25. Fregni F., Marcolin M.A., Myczkowski M., Amiaz R., Hasey G., Rumi D.O., Rosa M., Rigonatti S.P., Camprodon J., Walpoth M., Heaslip J., Grunhaus L., Hausmann A., Pascual-Leone A. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. International Journal of Neuropsychopharmacology 2006, 9:641-654.
26. Garcia P.A., Alldredge B.K. Drug-induced seizures. Neurologic Clinics 1994, 1:85-99.
27. Garcia-Toro M. Acute manic symptomatology during repetitive transcranial magnetic stimulation in a patient with bipolar depression. British Journal of Psychiatry 1999, 175:491.
28. George M., Wassermann E., Williams W., Callahan A., Ketter T.A., Basser P., Hallet M., Post R.M. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. NeuroReport 1995, 6:1853-1856.
29. George M.S., Nahas Z., Molloy M., Speer A.M., Oliver N.C., Li X.B., Arana G.W., Risch S.C., Ballenger J.C. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biological Psychiatry 2000, 48:962-970.
30. George M.S., Bohing D.E., Lorderbaum J.P., Nahas Z., Anderson B., Borckardt J.J., Molnar C., Kose S., Ricci R., Rastogi K. Overview of transcranial magnetic stimulation: history, mechanisms, physics, and safety. Transcranial Magnetic Stimulation in Clinical Psychiatry 2007, 1-38. American Psychiatry Publishing, Arlington, VA. M.S. George, R.H. Belmaker (Eds.).
31. Gilbert D.L., Garvey M.A., Bansal A.S., Lipps T., Zhang J., Wassermann E.J. Should transcranial magnetic stimulation research in children be considered minimal risk?. Clinical Neurophysiology 2004, 115(1730-173):9.
32. Graff-Guerrero A., Gonzáles-Olvera J., Ruiz-Garcia M., Avila-Ordoñez U., Vaugier V., García-Reyna J.C. rTMS reduces focal brain hyperperfusion in two patients with EPC. Acta Neurologica Scandinavica 2004, 4:290-296.
33. Grisaru N., Chudakov B., Yaroslavsky Y., Belmaker R. Transcranial magnetic stimulation in mania: a controlled study. American Journal of Psychiatry 1998, 155:1608-1610.
34. Gross M., Nakamura L., Pascual-Leone A., Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatrica Scandinavica 2007, 3:165-173.
35. Hammad T.A., Laughren T., Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 2006, 63:332-339.
36. Hausmann A., Kramer-Reinstadler K., Lechner-Schoner T., Walpoth M., Rupp C.I., Hinterhuber H., Conca A. Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report. Journal of Clinical Psychiatry 2004, 65:1575-1576.
37. Hemmer S.A., Pasternak J.F., Zecker S.G., Trommer B.L. Stimulant therapy and seizure risk in children with ADHD. Pediatric Neurology 2001, 24:99-102.
38. Huang C.C., Su T., Shan I. A case report of repetitive transcranial magnetic stimulation-induced mania. Bipolar Disorder 2004, 5:444-445.
39. Janicak P.G., O'Reardon J.P., Sampson S.M., Husain M.M., Lisanby S.H., Rado J.T., Heart K.L., Demitrack M.A. Transcranial magnetic stimulation in the treatment of major depression disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. Journal of Clinical Psychiatry 2008, 2:222-232.
40. Kennedy N., Boydell J., Kalidindi S., Fearon P., Jones P.B., van Os J., Murray R.M. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. American Journal of Psychiatry 2005, 162:257-262.
41. Kirton A., Deveber G., Gunraj C., Chen R. Neurocardiogenic syncope complicating pediatric transcranial magnetic stimulation. Pediatric Neurology 2008, 39:196-197.
42. Lee K.C., Finley P.R., Alldredge B.K. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opinion on Drug Safety 2003, 3:233-247.
43. Loo C., Sachdev P., Elsayed H., McDarmont B., Mitchell P., Wilkinson M., Parker G., Gandevis S. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients. Biological Psychiatry 2001, 49:615-623.
44. Loo C.K., Mitchell P.B., Croker V.M., Malhi G.S., Wen W., Gandevia S.C., Sachdev P.S. Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychological Medicine 2003, 33:33-40.
45. Loo C., McFarquhar T., Walter G. Transcranial magnetic stimulation in adolescent depression. Australasian Psychiatry 2006, 1:81-85.
46. Loo C.K., McFarquhar T.F., Mitchell P.B. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. The International Journal of Neuropsychopharmacology 2008, 11:131-147.
47. Mantovani A., Lisanby S.H. Transcranial Magnetic Stimulation in Major Depression. Transcranial Magnetic Stimulation in Clinical Psychiatry 2007, 113-151. American Psychiatric Publishing, Arlington, VA. M.S. George, R.H. Belmaker (Eds.).
48. March J., Silva S., Petrycki S., Curry J., Wells K., Fairbank J., Burns B., Domino M., McNulty S., Vitiello B., Severe J. Fluoxetine, cognitive-behavioral therapy and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association 2004, 292:807-820. Treatment for Adolescents with Depression Study (TADS) Team.
49. Morales O.G., Henry M.E., Nobler M.S., Wassermann E.M., Lisanby S.H. Electroconvulsive therapy and repetitive transcranial magnetic stimulation in children and adolescents: a review and report of two cases of epilepsia partialis continua. Child and Adolescent Psychiatric Clinics of North America 2005, 1:193-210. viii-ix.
50. Muller K., Homberg V., Lenard H.G. Magnetic stimulation of motor cortex and nerve roots in children. Maturation of corticomotorneural projections. Electroencephalography and Clinical Neurophysiology 1991, 81:63-70.
51. Nahas Z., Kozel F.A., Li X., Anderson B., George M. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disorder 2003, 5:40-47.
52. National Institute for Occupational Safety and Health (NIOSH): NIOSH Publication No. 98-126. 1998. Available at: Assessed April 23, 2009. http://www.cdc.gov/niosh/docs/98-126/98-126pd.html.
53. Nowak D.A., Hoffmann U., Connemann B.J., Schonfeldt- Lecuona C. Epileptic seizure following 1Hz repetitive transcranial magnetic stimulation. Clinical Neurophysiology 2006, 117:1631-1633.
54. O'Reardon J.P., Blumner K.H., Peshek A.D., Pradilla R.R., Pimiento P.C. Long-term maintenance therapy for major depressive disorder with rTMS. Journal of Clinical Psychiatry 2005, 12:1524-1528.
55. O'Reardon J., Solvason B., Janicak P., Sampson S., Isenberg K.E., Nahas Z., McDonald W.M., Avery D., Fitzgerald P.B., Loo C., Demitrack M.A., George M.S., Sackeim H. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multi-site randomized controlled trial. Biological Psychiatry 2007, 62:1208-1216.
56. Padberg F., Grossheinrich N., Pogarell O., Möller H., Fregni F. Efficacy and safety of prefrontal repetitive transcranial magnetic stimulation in affective disorders. Advances in Biological Psychiatry 2007, Vol. 23:53-83. Karger, Basel. M.A. Marcolin, F. Padberg (Eds.).
57. Pascual-Leone A., Houser C.M., Reese K., Shotland L.I., Grafman J., Sato S., Valls-Sole J., Brasil-Neto J.P., Wassermann E.M., Cohen L.G., Hallett M. Safety of rapid rate transcranial magnetic stimulation in normal volunteers. Electroencephalograpy and Clinical Neurophysiology 1993, 89:120-130.
58. Pisani F., Oteri G., Costa C., Raimondo G., Di Perri R. Effects of psychotrophic drugs on seizure threshold. Drug Safety 2002, 25:91-110.
59. Prikryl R., Kucerova H. Occurrence of epileptic paroxysm during repetitive transcranial magnetic stimulation treatment. Journal of Psychopharmacology 2005, 19:313.
60. Quintana H. Transcranial magnetic stimulation in persons younger than the age of 18. Journal of ECT 2005, 21:88-95.
61. Rachid F., Bertschy G. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: a critical appraisal of the last 10years. Neurophysiologie Clinique 2006, 3:157-183.
62. Rosa M., Picarelli H., Teixeira M., Rosa M., Marcolin M. Accidental seizure with repetitive transcranial magnetic stimulation. Journal of ECT 2006, 22:265-266.
63. Rosenstein D.L., Nelson J.C., Jacobs S.C. Seizures associated with antidepressants: a review. Journal of Clinical Psychiatry 1993, 8:289-299.
64. Sackeim H., Decina P., Prohovnik I., Malitz S. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and number of treatments. Archives of General Psychiatry 1987, 4:355-360.
65. Sakkas P., Mihalopoulou P., Mourtzouhou P., Psarros C., Masdrakis V., Politis A., Christodoulou G.N. Induction of mania by rTMS: report of two cases. European Psychiatry 2003, 18:196-198.
66. Su T.P., Huang C.C., Wei I.H. Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients. Journal of Clinical Psychiatry 2005, 66:930-937.
67. Substance Abuse and Mental Health Services Administration (SAMSHA) (2008). Major Depressive Episode among Youths Aged 12 to 17 in the United States: 2004 to 2006. NSDUH Report. (assessed 2009). http://www.oas.samhsa.gov/2k8/youthDepress/youthDepress.pdf.
68. Tharayil B.S., Gangadhar B.N., Thirthalli J., Anand L. Seizure with single-pulse transcranial magnetic stimulation in a 35-year-old otherwise-healthy patient with bipolar disorder. Journal of ECT 2005, 21:188-189.
69. U.S. Food and Drug Administration: Revisions to Product Labeling. Rockville, Md, FDA (2007). (accessed 2009). http://www.fda.gov/cder/drug/antidepressants/default.htm.
70. Valle A.C., Dionisio K., Pitskel N.B., Pascual-Leone A., Orsati F., Ferreira M.J., Boggio P.S., Lima M.C., Rigonatti S.P., Fregni F. Low and high frequency repetitive transcranial magnetic stimulation for the treatment of spasticity. Developmental Medicine & Child Neurology 2007, 7:534-538.
71. Walter G., Tormos J.M., Israel J.A., Pascual-Leone A. Transcranial magnetic stimulation in young persons: a review of known cases. Journal of Child and Adolescent Psychopharmacology 2001, 11:69-75.
72. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, 5-7 June 1996. Electroencephalogry and Clinical Neurophysiology 1998, 108:1-16.
73. Xia G., Gajwani P., Muzina D.J., Kemp D.E., Gao K., Ganocy S.J., Calabrese J.R. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. International Journal of Neuropsychopharmacology 2007, 5:1-12.
74. Zangen A., Roth Y., Voller B., Hallett M. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clinical Neurophysiology 2005, 116:775-779.
75. Zwanzger P., Ella R., Keck M., Rupprecht R., Padberg F. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biological Psychiatry 2002, 51:602-603.